
VEGF-D expression correlates with colorectal cancer aggressiveness and is downregulated by cetuximab
Author(s) -
Markus Moehler,
Christian Frings,
Annett Mueller,
Ines Gockel,
Carl C. Schimanski,
Stefan Biesterfeld,
Peter R. Galle,
Martin Holtmann
Publication year - 2008
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.14.4156
Subject(s) - cetuximab , colorectal cancer , epidermal growth factor receptor , medicine , cancer research , immunohistochemistry , vascular endothelial growth factor , lymph node , lymphangiogenesis , receptor , cancer , oncology , pathology , vegf receptors , metastasis
To gain mechanistic insights into the role played by epidermal growth factor receptor (EGFR) in the regulation of vascular endothelial growth factors (VEGFs) in colorectal cancer (CRC).